Navigation Links
Japanese Court Rules In Patients Favour Over Hepatitis C Scandal

A Japanese court has ruled that the pharmaceutical companies and the state were responsible for transmitting hepatitis C through a contaminated medical product// , and has awarded damages to nine people who had acquired the disease. The 13 plaintiffs who sued for damages were prescribed fibrinogen as well as other coagulants, between 1981 and 1988, made by the Green Cross Corp, a pharmaceutical that has closed down now.

The Osaka District Court on Wednesday, ordered the state and drug makers to pay a combined 256 million yen in damages to 9 of the 13 people who were infected after being treated with fibrinogen and other blood-clotting products. It was explained that fibrinogen was initially used very commonly to stop haemorrhaging during childbirth or surgery in the U.S. and Japan. The U.S. in 1977 had stopped using fibrinogen and issued warnings on its safety, but the Japanese regulators did not check the coagulant.

Toshitsugu Nakamoto the presiding judge had ruled that the drug maker, called then ‘Green Cross Corp’, was responsible for the nine who were infected after August 1985, as by then the risks became of the drugs had become known. He also had rejected damages for the four who unfortunately contracted the virus before the date. According to the ruling by the court, of the 13 people who were treated with fibrinogen and other blood-clotting drugs, five were awarded compensation from both the state and drug makers and four only from the drug makers.

The press report that this verdict marks the first time that a Japanese court has ruled in a series of lawsuits over the hepatitis C scandal.

'"/>




Page: 1

Related medicine news :

1. 45 People die in West Bengal due to Dengue and suspected Japanese Encephalitis
2. Japanese And Chinese Pharmaceutical Companies Join Together In Drug Testing
3. Woman Tests Negative For Japanese Encephalitis: Health Minister
4. Japanese-Indonesian Joint Venture To Produce Bird Flu Vaccine For Farm Animals
5. Schools set to offer Japanese language course
6. Girlie Needle And Thread help Japanese Men to De-Stress
7. Japanese Encephalitis Immunization Programme in India
8. Leprosy Cured People In India To Be Trained By Japanese Trust
9. Uttar Pradesh To Prepone The Japanese Encephalitis Immunisation Drive
10. Japanese Face High Risk Of Heart Attack And Stroke, Metabolic Syndrome to Blame
11. Japanese Scientists Develop Thought-Controlled Robotic Hands
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2016)... ... May 27, 2016 , ... In ... the many who are unaware of the plight of aphasia. In collaboration with ... the “Stroke Awareness” campaign. , The link between stroke and aphasia is relatively ...
(Date:5/27/2016)... ... 27, 2016 , ... Aimed at nurses and employees in ... courtesy of leaders in the nursing and health care industry. It also provides ... and associations—namely Jones & Bartlett Learning. , Jones & Bartlett Learning is adding ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... to students studying complementary medicine. Allison Outerbridge is this year’s Life University ... on May 18 at the university’s Student Leadership Awards ceremony. , Outerbridge is ...
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting at ... company to wait until March 2017 for an interest rate increase, according to Rajeev ... of Business. , “The Federal Open Market Committee (FOMC) dot charts are of interest ...
(Date:5/26/2016)... New Hampshire (PRWEB) , ... May 26, 2016 , ... ... skin care products, has been honored with a 2016 When Work Works Award for ... prestigious award, part of the national When Work Works project administered by the Families ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... , May 27, 2016 LabStyle ... Dario™ Diabetes Management Tool, today announced that the Company,s Chief ... Marcum MicroCap Conference being held June 1-2 in ... being held June 7-9 in Los Angeles, CA. ... discuss recent corporate and operational milestones, including the U.S. FDA ...
(Date:5/27/2016)... Kitov Pharmaceuticals ... late-stage drug development, today announced the completion of ... batches required for registration of KIT-302 with the ... Kitov,s announcement in December 2015, that ... primary efficacy endpoint. "We are fortunate ...
(Date:5/26/2016)... 2016 According to a new market ... - U.S. Industry Analysis, Size, Share, Growth, Trends, and Forecast ... U.S. was valued at US$ 5.89 Bn in 2014 and ... 2015 to 2023 to reach US$ 7.99 Bn in 2023. ... emerging needle free drug delivery devices and the market is ...
Breaking Medicine Technology: